Polaris Venture Management Co. V as of Sept. 30, 2016
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 9 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Selecta Biosciences (RNAC) | 28.9 | $27M | 1.9M | 14.25 | |
| Trevena | 14.6 | $14M | 2.1M | 6.75 | |
| T2 Biosystems | 14.3 | $14M | 1.9M | 7.24 | |
| Genocea Biosciences | 10.6 | $10M | 2.0M | 5.12 | |
| Fate Therapeutics (FATE) | 8.2 | $7.7M | 2.5M | 3.12 | |
| Ocular Therapeutix (OCUL) | 7.2 | $6.9M | 999k | 6.87 | |
| Pulmatrix | 6.3 | $6.0M | 3.6M | 1.65 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 6.1 | $5.8M | 1.8M | 3.18 | |
| Cerulean Pharma | 3.6 | $3.5M | 3.3M | 1.05 |
